CAPTRUST Financial Advisors
VYNT

CAPTRUST Financial Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40,545
Closed -$113K – 2245
2022
Q3 		$113K Buy
40,545
+40,535
+405,350% +$153K ﹤0.01% 1925
2022
Q2 		$0 Sell
10
-15
-60% -$66 ﹤0.01% 5240
2022
Q1 		$0 Buy
25
+15
+150% +$87 ﹤0.01% 5240
2021
Q4 		$0 Hold
10
– – ﹤0.01% 5005
2021
Q3 		$0 Hold
10
– – ﹤0.01% 4834
2021
Q2 		$0 Hold
10
– – ﹤0.01% 4724
2021
Q1 		$0 Hold
10
– – ﹤0.01% 4525
2020
Q4 		$0 Hold
10
– – ﹤0.01% 3561
2020
Q3 		$0 Sell
10
-25
-71% -$470 ﹤0.01% 3308
2020
Q2 		$0 Buy
+35
New +$546 ﹤0.01% 2926

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

CAPTRUST Financial Advisors's VYNT Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2022, closing a stake of 40,545 shares — an estimated $113K sold.

CAPTRUST Financial Advisors first reported a position in VYNT in Q2 2020 and held it in 10 quarters. The position peaked at $113K in Q3 2022. 17 funds tracked by Wall St. Rank hold VYNT as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 40,545 Vyant Bio, Inc. Common Stock shares in Q4 2022, an estimated $113K.
  • CAPTRUST Financial Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Vyant Bio, Inc. Common Stock position peaked at $113K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.